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Diabetes mellitus and the risk of nephrolithiasis.
Background. Insulin resistance is a central feature of type
2 diabetes mellitus (DM) and may increase the risk of kidney
stone formation. Existing cross-sectional data on the association
between DM and nephrolithiasis are limited, and no prospective
study to date has evaluated the relation between DM and the
risk of kidney stones.
Methods. To evaluate the relation between DM and prevalent
kidney stones, we conducted a cross-sectional study of 3 large
cohorts including over 200,000 participants: the Nurses’ Health
Study I (older women), the Nurses’ Health Study II (younger
women), and the Health Professionals Follow-up Study (men).
We then prospectively studied the association between DM and
incident nephrolithiasis over a combined 44 years of follow-up.
Because insulin resistance can precede the diagnosis of DM by
decades, we also prospectively examined the relation between
kidney stones and the diagnosis of incident DM. Multivariate
regression models adjusted for age, body mass index, thiazide
diuretic use, fluid intake, and dietary factors.
Results. At baseline, the multivariate relative risk of preva-
lent stone disease in individuals with DM compared to indi-
viduals without was 1.38 (95% CI 1.06-1.79) in older women,
1.67 (95% CI 1.28-2.20) in younger women, and 1.31 (95% CI
1.11-1.54) in men. Prospectively, the multivariate relative risk of
incident kidney stone formation in participants with DM com-
pared to participants without was 1.29 (95% CI 1.05-1.58) in
older women, 1.60 (95% CI 1.16-2.21) in younger women, and
0.81 (95% CI 0.59-1.09) in men. The multivariate relative risk
of incident DM in participants with a history of kidney stones
compared to participants without was 1.33 (95% CI 1.18-1.50)
in older women, 1.48 (95% CI 1.14-1.91) in younger women,
and 1.49 (95% CI 1.29-1.72) in men.
Conclusion. DM is a risk factor for the development of kid-
ney stones. Additional studies are needed to determine if the
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increased risk of DM in stone formers is due to subclinical in-
sulin resistance.
Nephrolithiasis is a major cause of morbidity. Approx-
imately 10% of men and 5% of women will experience
a symptomatic kidney stone by the age of 75 years [1–3],
and more than $2 billion is spent annually on the treat-
ment of stone disease [4, 5]. The identification of com-
mon systemic diseases that increase the risk of kidney
stone formation may help in the prevention of incident
and recurrent stones.
Type 2 diabetes mellitus is characterized by insulin re-
sistance [6], a metabolic derangement that may increase
the risk of kidney stone formation. Metabolic trials have
demonstrated that insulin resistance is associated with
defects in renal ammonium production [7, 8], and stone
formers with diabetes may have more acidic urine than
stone formers without diabetes [9]. Although a low uri-
nary pH plays a major role in the formation of uric acid
kidney stones [10, 11], a defect in renal acid excretion also
could lead to hypocitraturia, an important risk factor for
calcium stones [12, 13]. In addition, the compensatory hy-
perinsulinemia of insulin resistance [6] may increase the
urinary excretion of calcium [14–16].
Despite the compelling effect of insulin resistance on
urine composition, data on the potential association be-
tween diabetes and nephrolithiasis are sparse. One cross-
sectional study indicated that the prevalence of stone
disease in subjects with diabetes was 21%, compared to
8% in nondiabetic controls [17]. However, this study did
not adjust for body mass index, an important risk factor
for both diabetes and nephrolithiasis [18]. The results of
another cross-sectional study were inconclusive [19]. To
date, no prospective study has evaluated the association
between diabetes mellitus and the risk of kidney stones.
To determine if diabetes mellitus was associated with
prevalent kidney stones, we performed cross-sectional
analyses in 3 large cohorts: the Nurses’ Health Studies I
and II (NHS I and NHS II) and the Health Professionals
Follow-up Study (HPFS). We then prospectively studied
each cohort to examine the relation between diabetes
mellitus and incident nephrolithiasis. Because insulin
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resistance and compensatory hyperinsulinemia can pre-
cede the diagnosis of type 2 diabetes by decades [6], we
also evaluated kidney stones as a potential risk factor for
the diagnosis of incident diabetes.
METHODS
Study population
Nurses’ Health Study (NHS I). In 1976, 121,700 female
registered nurses between the ages of 30 and 55 years
completed and returned an initial questionnaire that pro-
vided detailed information on medical history, lifestyle,
and medications. This cohort, like NHS II and HPFS,
is followed by biennial mailed questionnaires, which in-
clude inquiries about the incidence of newly diagnosed
diseases, including diabetes and kidney stones. Because
we first asked NHS I participants about kidney stones
in 1992, the current analysis was limited to women who
answered questionnaires in 1992 or later. For this study,
we started follow-up in 1980 because before that date we
lacked information on diet.
Nurses’ Health Study II (NHS II). In 1989, 116,671 fe-
male registered nurses between the age of 25 and 42 years
enrolled in NHS II by completing and returning an ini-
tial questionnaire. Dietary information was first collected
from this cohort in 1991.
Health Professionals Follow-up Study (HPFS). In
1986, 51,529 male dentists, optometrists, osteopaths, phar-
macists, podiatrists, and veterinarians between the ages
of 40 and 75 years enrolled in HPFS by completing and
returning an initial questionnaire.
Ascertainment of diabetes mellitus
All participants who reported a diagnosis of diabetes
mellitus on a biennial questionnaire were sent a supple-
mentary questionnaire about symptoms, diagnostic tests,
and hypoglycemic therapy. Before 1996, a reported case
of diabetes mellitus was considered confirmed if at least 1
of the following was reported: (1) at least 1 typical symp-
tom (weight loss, hunger, excessive thirst, or polyuria)
and a fasting plasma glucose of at least 140 mg/dL or a
random plasma glucose of at least 200 mg/dL; (2) at least 2
elevated plasma glucose levels (fasting ≥140 mg/dL; ran-
dom, ≥200 mg/dL; and/or a concentration ≥200 mg/dL
after ≥2 hours on glucose tolerance testing) on differ-
ent occasions without symptoms; or (3) treatment with
a hypoglycemic medication (insulin or oral agents). Sub-
jects with confirmed diabetes mellitus who began taking
insulin within 1 year of diagnosis and who reported a his-
tory of ketoacidosis or ketonuria on at least 2 occasions
were considered to have type 1 diabetes mellitus. The fast-
ing glucose level for diagnosis was changed to 126 mg/dL
in June 1996, and this lower threshold was used to de-
fine cases after 1996. The criteria for the classification of
diabetes mellitus in the Nurses’ Health Study have been
published in detail previously [20].
In a sample of NHS I and HPFS participants, 98%
and 97% of the self-reported diabetes cases documented
by the supplementary questionnaire were confirmed by
medical record review [20, 21].
Ascertainment of kidney stones
The primary outcome was an incident kidney stone ac-
companied by pain or hematuria. The subjects reported
on the interval diagnosis of kidney stones every 2 years.
Any study participant who reported a new kidney stone
was sent an additional questionnaire to determine the
date of occurrence and the symptoms from the stone. We
confirmed the validity of the self-reported incident stones
in HPFS by obtaining medical records from 232 men in
the cohort; chart review confirmed 95% of the cases. We
also examined medical records from 194 women in NHS
I and 237 women in NHS II who reported incident kidney
stones. The records confirmed the diagnosis for 96% of
the cases in NHS I and 98% of the cases in NHS II.
Ascertainment of diet
The semiquantitative food-frequency questionnaire
(first mailed to the HPFS in 1986, to the NHS I in 1980,
and to the NHS II in 1991) asked about the average use
of more than 130 foods and beverages during the previ-
ous year. In addition, respondents provided information
on the use of nutritional supplements, taken either alone
or in multivitamin form. Subsequently, a version of this
food-frequency questionnaire (FFQ) has been mailed to
study participants every 4 years. The reproducibility and
validity of the FFQs in the HPFS and NHS I have been
documented [22, 23].
Nutrient intake was computed from the reported fre-
quency of consumption of each specified unit of food and
from USDA data on the content of the relevant nutrient
in specified portions. Nutrient values were adjusted for
total caloric intake to determine the composition of the
diet independent of the total amount of food eaten [24,
25].
The intake of supplemental calcium in multivitamin or
isolated form was determined by the brand, type, and
frequency of reported use.
Ascertainment of nondietary covariates
Information on age, weight, and height was obtained
on the baseline questionnaire. Self-reported weight was
updated every 2 years. Body mass index (BMI) was calcu-
lated as the weight in kilograms divided by the square of
height in meters. Self-reported weight has been validated
in HPFS and NHS I [26].
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In HPFS and NHS II, thiazide diuretic use was updated
every 2 years. In NHS I, thiazide use was determined in
1980, 1982, and then every 6 years until 1994, when bi-
ennial updates started. Information on hypertension was
obtained at baseline and then every 2 years. The validity
of self-reported hypertension has been documented [27].
Statistical analysis
Cross-sectional analyses. The cross-sectional analyses
assessed the prevalence of kidney stones according to the
presence or absence of a diagnosis of diabetes at base-
line (1980 for NHS I, 1991 for NHS II, and 1986 for
HPFS). Categorical variables were compared using the
chi-square test and continuous variables were compared
using analysis of variance (ANOVA). Logistic regression
was used to control for the following baseline covariates
simultaneously: age (continuous), BMI (continuous), al-
cohol intake (7 categories), the use of thiazide diuretics
(yes or no), supplemental calcium use (4 categories), and
the intake of fluid, sucrose, potassium, sodium, animal
protein, magnesium, phytate, and dietary calcium (quin-
tile groups).
Prospective analyses. For each cohort, we performed
2 prospective analyses. The first analysis evaluated dia-
betes mellitus (updated every 2 years) as a risk factor for
incident symptomatic kidney stone formation. Subjects
reporting a kidney stone at baseline were excluded at the
start of the study. The second prospective analysis eval-
uated a history of kidney stones (updated every 2 years)
as a risk factor for the development of incident type 2 di-
abetes. Participants reporting diabetes at baseline were
excluded at the start of the study.
For the NHS I, person-months of follow-up were
counted from the date of the return of the 1980 ques-
tionnaire to the date of an incident case (a kidney stone
for the first analysis, and type 2 diabetes for the second
analysis) or death or to May 31, 2000. For the NHS II,
person-months of follow-up were counted from the date
of the return of the 1991 questionnaire to the date of an
incident case or death or to May 31, 2001. For the first
prospective analysis of HPFS, person-months of follow-
up were counted from the date of the return of the 1986
questionnaire to the date of a kidney stone or death or to
January 31, 2000. Because we have only confirmed inci-
dent cases of type 2 diabetes in men through 1998, the
second prospective analysis of HPFS counted person-
months of follow-up from baseline to the date of diagnosis
of diabetes or death or to January 31, 1998. We allocated
person-months of follow-up according to exposure status
at the start of each 2-year follow-up period.
Cox proportional hazards regression was used to ad-
just for potential confounding in the prospective analyses.
The covariates included in the multivariate Cox models
were the same as for the logistic regression analyses, but
Table 1. Baseline characteristics of older women (NHS I), younger
women (NHS II), and men (HPFS) by diabetes mellitusa
Diabetes + Diabetes − P value
NHS I
Number % 1473 (1.9%) 74,266 (98.1%)
Age yearsb 48.6 46.3 <0.001
BMI kg/m2b 28.1 24.3 <0.001
Current thiazide use 329 (22.3%) 7382 (9.9%) <0.001
Kidney stone history 64 (4.3%) 2029 (2.7%) <0.001
NHS II
Number % 949 (1.0%) 94,485 (99.0%)
Age yearsb 37.6 36.1 <0.001
BMI kg/m2 b 29.0 24.6 <0.001
Current thiazide use 73 (7.7%) 1683 (1.8%) <0.001
Kidney stone history 58 (6.1%) 3093 (3.3%) <0.001
HPFS
Number % 1568 (3.2%) 47,737 (96.8%)
Age yearsb 60.9 54.4 <0.001
BMI kg/m2 b 26.4 25.5 <0.001
Current thiazide use 317 (20.2%) 4420 (9.3%) <0.001
Kidney stone history 177 (11.3%) 4002 (8.4%) <0.001
a1980 for NHS I, 1991 for NHS II, and 1986 for HPFS.
bValues expressed as means.
were updated throughout the study. Each dietary expo-
sure was updated every 4 years. If complete information
on diet was missing at the start of a time period, the sub-
ject was excluded for that time period.
We calculated 95% confidence intervals for all relative
risks. All P values are 2-tailed. All data were analyzed
by using SAS software, version 8.2 (SAS Institute, Inc.,
Cary, NC, USA). The research protocol for this study was
reviewed and approved by the institutional review board
of Brigham and Women’s Hospital.
RESULTS
Cross-sectional analyses
At the beginning of the study, 75,739 older women
(NHS I), 95,434 younger women (NHS II), and 49,305
men (HPFS) provided complete information on diabetes
mellitus, kidney stone disease, and diet. At baseline, 1473
older women (1.9%), 949 younger women (1.0%), and
1568 men (3.2%) reported a history of diabetes mellitus.
The characteristics of the study participants by history of
reported diabetes mellitus are shown in Table 1. Partici-
pants with diabetes mellitus were older (P < 0.001), had a
higher BMI (P < 0.001), were more likely to use thiazide
diuretics (P < 0.001), and were more likely to report a
history of kidney stones (P < 0.001).
A history of diabetes mellitus was independently as-
sociated with a history of nephrolithiasis in all 3 cohorts
(Table 2). The multivariate relative risk of prevalent kid-
ney stones in participants with diabetes mellitus com-
pared to participants without was 1.38 (95% CI 1.06-
1.79) in older women, 1.67 (95% CI 1.28-2.20) in younger
women, and 1.31 (95% CI 1.11-1.54) in men. Further
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Table 2. Baseline relative risk of prevalent nephrolithiasis according
to diabetes history in older women (NHS I), younger women (NHS
II), and men (HPFS)a
Age-adjusted RR Multivariate RRb
NHS I
Diabetes – 1.00 (reference) 1.00 (reference)
Diabetes + 1.55 1.38
(1.20, 1.99) (1.06, 1.79)
NHS II
Diabetes – 1.00 (reference) 1.00 (reference)
Diabetes + 1.84 1.67
(1.41, 2.41) (1.28, 2.20)
HPFS
Diabetes – 1.00 (reference) 1.00 (reference)
Diabetes + 1.21 1.31
(1.03, 1.42) (1.11, 1.54)
a1980 for NHS I, 1991 for NHS II, and 1986 for HPFS.
bRelative risks (RR) include 95% confidence intervals in parentheses. The
multivariate model includes age, body mass index, use of thiazide diuretics (yes
or no), fluid intake (in quintiles), alcohol use (7 categories), calcium supplement
use (4 categories), and dietary intake of calcium, animal protein, potassium,
sodium, phytate, magnesium, and sucrose (all in quintiles).
adjustment for hypertension did not materially change
the results.
Prospective analyses
Incident kidney stone formation according to diabetes
history. After excluding participants who reported a his-
tory of kidney stones at baseline, we prospectively studied
93,758 older women (NHS I), 101,877 younger women
(NHS II), and 46,062 men (HPFS). Over the course of
the study, we documented a total of 4688 incident kid-
ney stones (1687 in NHS I, 1531 in NHS II, and 1470 in
HPFS).
A self-reported history of diabetes mellitus was inde-
pendently associated with an increased risk of incident
nephrolithiasis in women, but not men (Table 3). The mul-
tivariate relative risk of kidney stone formation in partic-
ipants with self-reported diabetes mellitus compared to
participants without was 1.29 (95% CI 1.05-1.58) in older
women, 1.60 (95% CI 1.16-2.21) in younger women, and
0.81 (95% CI 0.59-1.09) in men. Excluding participants
with diabetes mellitus at baseline (i.e., restricting the anal-
yses to confirmed cases of incident type 2 diabetes mel-
litus) and further adjustment for hypertension did not
materially change the results.
Incident diabetes according to kidney stone history. Af-
ter excluding participants who reported a history of dia-
betes at baseline, we prospectively studied 94,448 older
women (NHS I), 104,911 younger women (NHS II), and
49,101 men (HPFS). Over the course of the study, we doc-
umented a total of 6460 incident cases of type 2 diabetes
(4300 in NHS I, 785 in NHS II, and 1375 in HPFS).
A self-reported history of kidney stones was indepen-
dently associated with an increased risk of incident di-
abetes in women and men (Table 4). The multivariate
Table 3. Relative risk of incident symptomatic kidney stones
according to diabetes history in older women (NHS I), younger
women (NHS II), and men (HPFS)a
Person- Kidney Age-adjusted Multivariate
years stones RR RRb
NHS I
Diabetes – 1,371,080 1578 1.00 (reference) 1.00 (reference)
Diabetes + 65,566 109 1.45 1.29
(1.20, 1.77) (1.05, 1.58)
NHS II
Diabetes – 824,076 1491 1.00 (reference) 1.00 (reference)
Diabetes + 12,291 40 1.86 1.60
(1.36, 2.56) (1.16, 2.21)
HPFS
Diabetes – 450,984 1426 1.00 (reference) 1.00 (reference)
Diabetes + 21,676 44 0.76 0.81
(0.56, 1.03) (0.59, 1.09)
aSubjects who reported kidney stones on the baseline questionnaire were
excluded.
bRelative risks (RR) include 95% confidence intervals in parentheses. The
multivariate model includes age, body mass index, use of thiazide diuretics (yes
or no), fluid intake (in quintiles), alcohol use (7 categories), calcium supplement
use (4 categories), and dietary intake of calcium, animal protein, potassium,
sodium, phytate, magnesium, and sucrose (all in quintiles).
Table 4. Relative risk of incident type 2 diabetes according to kidney
stone history in older women (NHS I), younger women (NHS II), and
men (HPFS)a
Person- Age-adjusted Multivariate
years Diabetes RR RRb
NHS I
Stones – 1,522,293 4005 1.00 (reference) 1.00 (reference)
Stones + 64,590 295 1.65 1.33
(1.47, 1.86) (1.18, 1.50)
NHS II
Stones – 988,262 712 1.00 (reference) 1.00 (reference)
Stones + 44,290 73 2.26 1.48
(1.78, 2.88) (1.14, 1.91)
HPFS
Stones – 399,935 1157 1.00 (reference) 1.00 (reference)
Stones + 44,373 218 1.54 1.49
(1.33, 1.78) (1.29, 1.72)
aSubjects who reported diabetes on the baseline questionnaire were excluded.
bRelative risks (RR) include 95% confidence intervals in parentheses. The
multivariate model includes age, body mass index, use of thiazide diuretics (yes
or no), fluid intake (in quintiles), alcohol use (7 categories), calcium supplement
use (4 categories), and dietary intake of calcium, animal protein, potassium,
sodium, phytate, magnesium, and sucrose (all in quintiles).
relative risk of diabetes in participants with self-reported
kidney stones compared to participants without was 1.33
(95% CI 1.18-1.50) in older women, 1.48 (95% CI 1.14-
1.91) in younger women, and 1.49 (95% CI 1.29-1.72) in
men. Excluding participants with kidney stones at base-
line did not materially change the results.
DISCUSSION
Our study found that diabetes mellitus was positively
associated with nephrolithiasis, independent of age, BMI,
thiazide diuretic use, and diet. Diabetes was associated
with prevalent stone disease in all 3 cohorts, and was as-
sociated with an increased risk of incident kidney stone
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formation in older and younger women. In addition, a
history of kidney stones was associated with an increased
risk of incident type 2 diabetes in men and women.
Diabetes may increase the risk of kidney stone forma-
tion by altering the composition of the urine. Insulin re-
sistance, a central feature of type 2 diabetes, may manifest
in the kidney as a defect in ammonium production [7, 8].
Insulin resistance is associated with high levels of plasma
free fatty acids, which can enter the proximal tubule cells
and interfere with the utilization of glutamine in the
production of ammonium [28–30]. In addition, insulin
resistance at the level of the kidney may directly affect
ammoniagenesis. In vitro studies demonstrate that in-
sulin stimulates renal ammonium production from the
substrate L-glutamine [31, 32]. Insulin may also play a
role in the function of the proximal renal tubule Na+/H+
exchanger that is needed for either direct transport or
ionic trapping of ammonium in the tubular lumen [33].
In vivo data in humans have confirmed that insulin
plays an important role in renal acidification by increas-
ing the production of ammonium, and that insulin resis-
tance is associated with an impaired ability to excrete an
acid load [7, 8]. In a recent metabolic trial, 13 patients
with a history of recurrent uric acid nephrolithiasis and
55 healthy volunteers underwent hyperinsulinemic eug-
lycemic clamp [8]. In the healthy volunteers, insulin levels
increased from a mean of 14 microunits/mL at baseline to
173 microunits/mL during the last 40 minutes of insulin
infusion [8]. The levels of urinary ammonium in these
subjects during this time frame increased by 48%, and
urinary pH increased from a mean of 6.1 to 6.8 [8]. Of
note, lower glucose disposal rate (i.e., greater insulin re-
sistance) correlated significantly with lower urinary pH
(P = 0.01) in all subjects [8].
Other clinical data indirectly support the results of this
metabolic trial. For instance, stone formers with diabetes
may have more acidic urine than stone formers without
diabetes [9]. Higher weight, which is associated with in-
sulin resistance, was inversely associated with urinary pH
in a study of over 4800 patients with nephrolithiasis [34].
Although low urinary pH is a major risk factor for uric
acid nephrolithiasis [10, 11], an impaired ability to excrete
acid also could increase the risk for calcium-containing
kidney stones by decreasing the urinary excretion of cit-
rate [13]. In addition, the compensatory hyperinsuline-
mia of type 2 diabetes may increase the supersaturation
of the urine with respect to calcium salts. Over 30 years
ago, seminal work demonstrated that the ingestion of glu-
cose or sucrose decreased the tubular reabsorption of
filtered calcium [35] and increased urinary calcium ex-
cretion [36]. Subsequent animal experiments showed that
this “carbohydrate-induced calciuria” could be inhibited
by pharmacologically blocking the pancreatic secretion
of insulin [37]. Experiments in humans undergoing eug-
lycemic hyperinsulinemic clamp suggest that insulin, by
an unknown mechanism, may increase the fractional ex-
cretion of calcium [14–16].
The prospective analysis in the male cohort failed to
find an association between diabetes mellitus and the risk
of incident stone formation, a result that differed from
the cross-sectional analysis in men and both the cross-
sectional and prospective analyses in older and younger
women. This may be due to the older age (nearly 61 years)
of diabetics in the male cohort at the start of the study.
Because insulin resistance and compensatory hyperinsu-
linemia can precede the diagnosis of type 2 diabetes mel-
litus by decades [6], and because we excluded men with a
history of kidney stones at baseline, our prospective anal-
ysis may have included diabetic men who were unlikely
to develop kidney stones.
Because a kidney stone is unlikely to cause diabetes
directly, the positive association between nephrolithi-
asis and subsequent diabetes suggests that a common
metabolic defect may contribute to the development of
both diseases. Insulin resistance and compensatory hy-
perinsulinemia could manifest as an increased suscepti-
bility to kidney stones years before the actual diagnosis of
diabetes. Stone formers were more likely to take thiazide
diuretics, and these medications may increase the risk of
type 2 diabetes [38]. However, we adjusted our analysis
for the use of thiazide diuretics.
The limitations of our study deserve mention. We did
not confirm all self-reported cases of incident type 2 di-
abetes, and some participants with diabetes at baseline
may have had type 1 diabetes. However, these misclassi-
fications are likely to be random with respect to case sta-
tus, and therefore would bias the study results toward the
null. The generalizability of our results also may be lim-
ited. Only a small proportion of our study population is
non-white, and we do not have data on stone formation in
men younger than 40 years of age. It is unknown whether
age and race modulate the effect of insulin on urine com-
position. Finally, we currently lack 24-hour urine samples
and stone composition analyses from most of the partic-
ipants in our study. Thus, we were unable to determine if
diabetes increases the risk of certain stone types, such as
uric acid, but not others.
CONCLUSION
Diabetes mellitus is associated with an increased risk
of kidney stone formation. Our study also demonstrates
that a history of kidney stones increases the likelihood of
a subsequent diagnosis of type 2 diabetes. Because this
relation may be due to subclinical insulin resistance, it
is reasonable to screen new stone formers for diabetes.
Our study provides further evidence that nephrolithiasis
is a systemic metabolic disorder, and suggests that the
incidence and prevalence of stone disease will continue
to increase as type 2 diabetes becomes more common.
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